AI-driven drug discovery company
Location: United States, Massachusetts, Cambridge
Total raised: $10M
Investors 3
Date | Name | Website |
- | S16VC | s16vc.com |
- | Phoenix Ve... | phoenix-vp... |
- | Tachyon Ve... | tachyon.vc |
Funding Rounds 1
Date | Series | Amount | Investors |
14.09.2020 | Seed | $10M | - |
Mentions in press and media 6
Date | Title | Description |
16.06.2021 | Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci | SHANGHAI, June 16, 2021 /PRNewswire/ -- Viva Biotech (01873.HK) declared today that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the potential of proteins as next-generation ther... |
24.03.2021 | Totient Announces Formation of the New Scientific Advisory Board | |
18.09.2020 | StartUPDATES: New developments from healthcare startups | Carrum Health is expanding into Indiana through a partnership with OrthoIndy Hospital to provide Indiana employers, employees and their dependents access to high-quality orthopedic services at predictable costs. A RAND Corporation study fou... |
14.09.2020 | Totient Raises $10M in Seed Funding | Totient, a Cambridge, Mass.-based AI-driven drug discovery company, emerged from stealth with $10M in seed funding. Backers included Mission BioCapital, Sands Capital, Viva Biotech, Kaitai Capital, Tau Ventures, Jonathan Milner, and more. F... |
10.09.2020 | Totient Exits Stealth With $10M Seed Round | CAMBRIDGE, MA, Totient, an AI-driven drug discovery company has emerged from stealth with $10 million in seed funding and a strategic discovery partnership for COVID-19. >> Click here for more funding data on Totient >> To e... |
- | StartUPDATES: New developments from healthcare startups | Carrum Health is expanding into Indiana through a partnership with OrthoIndy Hospital to provide Indiana employers, employees and their dependents access to high-quality orthopedic services at predictable costs. A RAND Corporation study fou... |